Mr. Strange is chairman and CEO of Intelligent Systems. He is an inductee in the Georgia Technology Hall of Fame as well as the Hall of Fame of the Georgia Tech College of Management.
Mr. Strange is on the Board of Trustees and past Chairman of the Georgia Tech Research Corporation. and is on the advisory board of Georgia Tech’s College of Management as well as a trustee emeritus of the Georgia Tech Foundation. He also serves as a trustee on the Georgia Gwinnett College Foundation and the Georgia Baptist Health Care Ministry Foundation.
In the past, he has served on the board of publicly traded companies such as Allied Automotive Group (NYSE:AHI), Great Plains Software, Matria Healthcare, Healthdyne Technologies and IQ Software.
Prior to being appointed President of Intelligent Systems, Mr. Strange founded Quadram Corporation in 1980. Quadram pioneered the enhancement products industry as one of the fastest growing electronics companies in the U.S in the early years of the personal computer industry. Mr. Strange received a BS degree in Industrial Management from Georgia Institute of Technology and a MBA from Georgia State University.
Karen Reynolds was appointed CFO and Corporate Secretary of Intelligent Systems in 2016 with responsibility for financial and SEC reporting, legal and contract matters, corporate governance and due diligence. Prior to this role she was CFO of CoreCard Software, Inc., Intelligent Systems’ principal operating business. Ms. Reynolds remains as the CFO for CoreCard, functioning in a dual capacity on both the corporate and subsidiary management teams.
Prior to joining CoreCard, she was President and CFO of zBoost, a privately held technology company, from 2008 until 2015, where she immersed herself in the firm’s technology, briefed FCC commissioners regarding her company’s industry, and expanded zBoost into new markets. Karen has been recognized for her leadership and contribution to the Atlanta technology community and was named as a 2014 Women of the Year in Technology Finalist.
For more than 25 years, Karen Reynolds’ career has included executive roles in finance and accounting, strategy, operations and corporate transactions at both entrepreneurial and large corporations in a variety of technology and services industries. A graduate of Purdue University with a Bachelor of Science in General Management and Accounting, she is also a Certified Public Accountant and Certified Global Management Accountant.
Philip H. Moise was elected to the Board in 2013. Mr. Moise served as Executive Vice President, General Counsel and Secretary of Immucor, Inc. from 2007 until 2012. Immucor manufactures and sells instruments and reagents used to classify components of human blood prior to blood therapies and transfusions. Previously a publicly-held company, Immucor was acquired and taken private in 2011. Before joining Immucor, Mr. Moise was in the private practice of law for almost 30 years, where he represented public and private companies in the technology and life sciences industries. He represented Intelligent Systems for approximately 25 years before joining Immucor in 2007.
Parker (Pete) H. Petit has served as a director since 1996. Mr. Petit is the Chairman, President and CEO of MiMedx Group, an integrated developer, manufacturer and marketer of bio-material based products. Mr. Petit is also the President of The Petit Group, a private investment company. Mr. Petit served as Chairman of the Board and Chief Executive Officer of Matria Healthcare, Inc., a comprehensive disease management services company from 1996 to 2008.